Conferences - Results from #8920

Viewing 8921-8940 of 11721 articles

CUA 2017: Role of Androgen Deprivation in Salvage Radiotherapy

CUA 2017: Intraductal Prostate Cancer: Marker of Aggressive Disease?

CUA 2017: Liquid Biopsy in Personalizing CRPC Therapy

TAT-10: Efficacy of Actinium-225-labeled Anti-CD33 Antibody in Acute Myeloid Leukemia Correlates with Peripheral Blast Count

TAT-10: Bi-213-anti-EGFR-Mab Therapy of Recurrent Bladder Cancer - A Pilot Study

TAT-10: Targeted Alpha Therapy of Glioblastoma Multiforme: Clinical Experience with Bi213 and Ac225-Substance P

TAT-10: Dosimetry and Biodistribution of Pb203-AR-RMX in Patients with Somatostatin Expressing Neuroendocrine Tumors: A Clinical Exploratory Study

TAT-10: Ac225-PSMA-617: PSMA Targeting Alpha-Radiation Therapy of Patients with mCRPC

TAT-10: Radium-223 in Asymptomatic Metastatic Castration Resistance Prostate Cancer Patients Treated in an International Early Access Program (iEAP)

TAT-10: Changes to Alkaline Phosphatase Dynamics and Overall Survival in Metastatic Castration-Resistant Prostate Cancer Patients Treated with Radium-223 in an International Early Access Program

TAT-10: Reduction of Radiation Exposure to the Large Intestine During Ra223 Alpha Therapy with Oral Administration of Barium Sulfate

TAT-10: Pharmacokinetic Profiling and Therapeutic Efficacy of Alpha-emitter Labeled Ant-PD1.1 Antibodies in an Immune Competent Transgenic Breast Cancer Model

TAT-10: Novel IgG t Melanin Show Promise for Radioimmunotherapy of Metastatic Melanoma

TAT-10: Preclinical Evaluation of Anti-HER2 2Rs15d Nanobody Labeled with Ac225

TAT-10: Preclinical Evaluation of Astatinated Nanobodies for Targeted Alpha Therapy

TAT-10: Development of Alpha-emitting At111-meta-astotbenzylguanidine (At211-MABG) as a Novel Therapeutic Agent for Malignant Pheochromocytoma

TAT-10: Directing Alpha-emitting Conjugates to Cancer Chromatin via PARP-1

TAT-10: Locoregional alpha-radioimmunotherapy against peritoneal metastasis of gastric cancer

TAT-10: A comparative evaluation of Ac225 and Bi213 as therapeutic radioisotopes for targeted alpha therapy

TAT-10: Optimization of the patient dosimetry in alphatherapy

442
443
444
445
446
447
448
449
450
451